Margaret Tooth Sells 4,500 Shares of Trupanion Inc (NYSE:TRUP) Stock
Trupanion Inc (NYSE:TRUP) insider Margaret Tooth sold 4,500 shares of the stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $23.00, for a total value of $103,500.00. Following the completion of the sale, the insider now owns 4,502 shares of the company’s stock, valued at $103,546. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Trupanion Inc (NYSE:TRUP) traded down 0.35% during midday trading on Tuesday, reaching $22.81. The company’s stock had a trading volume of 92,268 shares. The stock’s 50-day moving average price is $22.63 and its 200 day moving average price is $17.84. Trupanion Inc has a 1-year low of $13.71 and a 1-year high of $25.00. The firm’s market capitalization is $684.19 million.
Trupanion (NYSE:TRUP) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.01. The business had revenue of $58.30 million during the quarter, compared to analysts’ expectations of $57.58 million. Trupanion had a negative return on equity of 13.24% and a negative net margin of 2.71%. The business’s quarterly revenue was up 27.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.03) EPS. Equities analysts anticipate that Trupanion Inc will post ($0.12) EPS for the current fiscal year.
TRUP has been the subject of a number of research analyst reports. Northland Securities initiated coverage on Trupanion in a research note on Friday, May 26th. They issued an “outperform” rating and a $22.75 price target for the company. ValuEngine upgraded Trupanion from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Cowen and Company reiterated a “buy” rating and issued a $19.00 price target on shares of Trupanion in a research note on Friday, July 14th. Zacks Investment Research upgraded Trupanion from a “sell” rating to a “hold” rating in a research note on Tuesday, July 18th. Finally, TheStreet upgraded Trupanion from a “d” rating to a “c-” rating in a research note on Monday, July 17th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $24.50.
Several hedge funds have recently made changes to their positions in the stock. Royce & Associates LP boosted its stake in shares of Trupanion by 190.6% in the second quarter. Royce & Associates LP now owns 52,300 shares of the financial services provider’s stock worth $1,170,000 after buying an additional 34,300 shares during the period. American Century Companies Inc. purchased a new stake in shares of Trupanion during the second quarter worth about $3,434,000. Bank of New York Mellon Corp boosted its stake in shares of Trupanion by 31.2% in the second quarter. Bank of New York Mellon Corp now owns 74,800 shares of the financial services provider’s stock worth $1,674,000 after buying an additional 17,809 shares during the period. Rhumbline Advisers boosted its stake in shares of Trupanion by 57.9% in the second quarter. Rhumbline Advisers now owns 23,944 shares of the financial services provider’s stock worth $536,000 after buying an additional 8,777 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in shares of Trupanion by 75.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 37,300 shares of the financial services provider’s stock worth $835,000 after buying an additional 16,000 shares during the period.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.